Aventis SWOT Analysis, USP & Competitors

Posted in Pharmaceuticals and Healthcare, Total Reads: 1125
Advertisements

SWOT Analysis of Aventis with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis

Aventis

Parent Company

Aventis

Category

Pharmaceutical

Sector

Healthcare

Tagline/ Slogan

Creating a symphony of success

USP

After merger with Sanofi it has become world’s largest pharmaceutical company

STP

Segment

Cardiovascular, CNS, diabetes, thrombosis, oncology

Target Group

Healthcare professionals, doctors & hospitals

Positioning

World class pharmaceutical manufacturer

SWOT Analysis

Strengths

1. Strong brand building capabilities

2. Six blockbuster products which feature in top 110 brands

3. Broad portfolio of anti-diabetic drugs

4. Acquisition of well known brands of UMPL

5. Sturdy and stable financial position

Weaknesses

1. Largely dependent on Indian market for revenue generation

2. Limited presence in emerging markets

3. Its parent company Sanofi has laid off quite a few employees which has generated lot of negative publicity for company

Opportunities

1. Strong growth of Indian pharmaceutical market

2. Increasing health awareness

3. Increasing number of diabetic patients

Threats

1. Increasing price pressures

2. high inflation in Indian market

3. Global economic slowdown

Competition

Competitors

1. Sun pharmaceuticals

2. Novartis

3. Cipla

4. Pfizer



Advertisements



Looking for More Brands? Search BrandGuide

Edit the Brand or Add a New One : Contribute to BrandGuide

The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only.
Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.